Articulus Surgical, a deeptech medical device startup building an indigenous, interoperable surgical robotics ecosystem for minimally invasive soft-tissue surgery, has raised an undisclosed amount in a seed funding round led by Kalaari Capital.
The startup said that despite more than 200 million abdominal surgeries performed globally each year, robotic surgery penetration remains at around 5% worldwide and under 1% in India. Articulus Surgical aims to address this gap with an India-built platform designed for high-volume procedures across diverse healthcare settings.
The startup will use the raised capital to accelerate market rollout, expand hospital deployments, strengthen surgeon training initiatives, and deepen strategic hospital partnerships across India.
Saurya Mishra, Founder & CEO, Articulus Surgical, said, “This funding allows us to shift focus to scale and adoption, bringing advanced, minimally invasive surgical technology to more hospitals and surgeons, while staying true to our self-reliant Make-in-India vision with global relevance, driven by a great, young team and an unwavering focus on patient care.”
Pranav Koshal, Vice President, Kalaari Capital, added, “Accessible, high-quality healthcare remains one of the most critical whitespace opportunities in India, where millions of patients still lack access to world-class surgical care. We’re excited to back Saurya and the team at Articulus Surgical, who are building a vertically integrated, India-native platform of affordable robotic surgical systems. Their approach is focused on bringing precision, safety, and minimally invasive procedures within reach of surgeons and patients across the country precisely the kind of impact-driven innovation India needs”
The startup said that its flagship system, Pulsar, is a first-of-its-kind modular surgical robotics platform designed for high-volume minimally invasive procedures.
It has also developed Galaxi, an intelligent surgical optics robot, and Nebula, a surgical robotics simulation and training system, which is already in production and commercial deployment.
Over the next 12 to 18 months, Articulus Surgical plans to increase deployments across Indian hospitals, establish dedicated surgeon training centres, and focus on high-volume procedures across general surgery, gynaecology, urology, gastrointestinal surgery, and surgical oncology.
